公开(公告)号：EP1254895B1

公开(公告)日：2007-05-23

申请号：EP01901413.3

申请日：2001-01-18

申请人： Eisai R&D Management Co., Ltd.

发明人： YAMAMOTO, Noboru ,  SUZUKI, Yuichi ,  KIMURA, Manami ,  NIIDOME, Tetsuhiro ,  IIMURA, Yoichi ,  TERAMOTO, Tetsuyuki ,  KANEDA, Yoshihisa ,  KANEKO, Toshihiko ,  KURUSU, Nobuyuki ,  SHINMYO, Daisuke ,  YOSHIKAWA, Yukie ,  HATAKEYAMA, Shinji

IPC分类号： C07D333/26 ,  A61K31/495 ,  A61K31/381 ,  A61P9/10

CPC分类号： C07D207/337 ,  C07D207/09 ,  C07D207/14 ,  C07D207/16 ,  C07D209/14 ,  C07D209/42 ,  C07D211/22 ,  C07D211/26 ,  C07D211/32 ,  C07D211/34 ,  C07D211/46 ,  C07D211/58 ,  C07D211/64 ,  C07D213/36 ,  C07D213/57 ,  C07D213/74 ,  C07D215/06 ,  C07D215/12 ,  C07D215/227 ,  C07D215/38 ,  C07D217/04 ,  C07D217/22 ,  C07D235/14 ,  C07D235/30 ,  C07D241/04 ,  C07D243/08 ,  C07D261/08 ,  C07D263/20 ,  C07D263/32 ,  C07D263/58 ,  C07D271/06 ,  C07D277/28 ,  C07D277/42 ,  C07D277/82 ,  C07D295/145 ,  C07D295/185 ,  C07D295/192 ,  C07D295/215 ,  C07D307/52 ,  C07D307/54 ,  C07D307/81 ,  C07D319/20 ,  C07D333/24 ,  C07D333/28 ,  C07D333/38 ,  C07D333/60 ,  C07D401/04 ,  C07D401/06 ,  C07D401/12 ,  C07D403/04 ,  C07D405/06 ,  C07D409/06 ,  C07D409/12 ,  C07D409/14 ,  C07D413/04 ,  C07D413/12 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D471/10 ,  C07D487/08

摘要： Novel compounds exhibiting excellent calcium antagonism, particularly neuroselective calcium antagonism, namely, compounds of the general formula (I), salts of the same, or hydrates of both wherein Ar is a group derived from an optionally substituted 5- to 14-membered aromatic ring, or the like; the ring A is one member selected from among piperazine, homopiperazine, piperidine and so on; the ring B is an optionally substituted C3-14 hydrocarbon ring or the like; E is a single bond, -CO-, or the like; X is a single bond, oxygen, or the like; R1 is hydrogen, halogeno, hydroxyl, or the like; and D?1, D2, W1 and W2¿ are each independently a single bond or optionally substituted C¿1-6? alkylene.